undamentalytics Newsletter
Sign in

Edwards Lifesciences income statement

In fiscal 2025, Edwards Lifesciences reported revenue of $6.07bn, up 11.5% on the year before, operating income of $1.26bn (a 20.8% margin) and net income of $1.07bn, or $1.83 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1,3211,4471,6791,9002,0462,3232,4942,9643,4353,7234,3484,3865,2334,4645,0105,4406,0686,512
Cost of revenue3994084904915176266177978759391,1141,0811,2497249781,1181,3341,443
Gross profit9221,0391,1891,4091,5291,6971,8772,1662,5602,7833,2343,3063,9843,7404,0324,3224,7335,069
Research and development1762042462913233473834425536227537619038449631,0531,0791,091
Selling, general and administrative5095506426977338588519059911,0891,2421,2281,4941,3581,5831,7892,0852,201
Operating income———————7511,0897481,1478981,6901,4981,3091,3791,2641,449
Interest expense323410171719233021161819182020—
Net interest income—————————−30————−18−20−20−31
Income before tax3042682843885111,1446227381,0357611,1679171,7021,5201,3721,5481,2731,418
Income tax755047971223331281684513912093199196152152217439
Net income2292182372923898114955705847221,0478231,5031,5221,4024,1751,0741,005
Diluted EPS$0.33$0.30$0.33$0.41$0.57$1.25$0.75$0.87$0.90$1.13$1.64$1.30$2.38$2.44$2.30$6.97$1.83$1.73
Diluted shares (average)705m715m716m710m683m651m661m653m648m641m637m632m631m624m609m599m586m581m
EBITDA———————8221,1718261,2361,0051,8251,6381,4541,5341,4211,615

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: EW vs STEEW vs RMDBLCO vs EWEW vs ZBH

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Edwards Lifesciences's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Edwards Lifesciences.